Clinical Trial

An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to evaluate the tolerability and safety of MWAV201 in patients with Wilson disease.
Protocol Amendment History 2 changes
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-08-13
notable Primary completion pushed: 2026-03 -> 2031-03 2026-08-13
Trial Details
NCT Number NCT06663878
Lead Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators: Mabwell (Shanghai) Bioscience Co., Ltd.
Conditions Wilson Disease
Enrollment 9 participants
Start Date 2024-10-28
Primary Completion 2031-03 (estimated)
Study Completion 2031-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-12